Adriano de Bernardi Schneider, MS, PhD Candidate, Contagion® Editorial Advisory Board Member, provides a brief snapshot into some of his work on mapping the evolution of the Zika virus.
Infectious diseases clinicians turn to Twitter as a tool for education and collaboration.
When the CD4 count seems too good to be true.
As of October 31, 2018, the CDC has reported 457 clinical cases of confirmed C auris infection with a majority in New York (>50%), New Jersey, and Illinois.
A review of the current literature and future directions.
The panel concludes its discussion by talking about resources available for providers in managing their patients with HIV who experience drug resistance.
Dr. Rodney E. Rohde, clinical laboratory scientist, discusses campus reopening as well as his work on rabies eradication.
Candida auris—Are we prepared for another multidrug-resistant pathogen?
A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.
Several recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.
The globalization of antibiotic stewardship programs is necessary in the fight against antibiotic resis­tance.
Frontline health care workers had a nearly 12 times higher risk of testing positive for COVID-19 compared with individuals in the general community.
Hospital-acquired and ventilator-associated pneumonia account for 22% of all hospital-acquired infections.
This In the Literature piece details a study evaluating the effects of ID consultation for OPAT patients.
Invasive aspergillosis affects up to 13% of immunocompromised patients who are in the hospital.
Early diagnosis and treatment were essential to ensuring a good prognosis.
A novel NNRTI hits the market, but what place will it have in treatment?
As the population of people living with HIV infection is living longer, age-related health issues are affecting these individuals in an accelerated or emphasized fashion.
Here is a brief report of 5 cases of the use of fecal microbiota, live-jslm (Rebyota) in the management of recurrent Clostridioides difficile infection.
Aerosolized antibiotics are a reasonable adjunctive option to treat multidrug-resistant gram-negative pneumonia due to excellent pulmonary concentrations and few adverse effects.
A shocking find on a CT scan leads to an unexpected diagnosis.
A case of Kaposi sarcoma with immune reconstitution inflammatory syndrome.
Panelists hypothesize on theoretical downsides of resistance development for gram-negative infections and reflect on the importance of implementing outpatient parenteral antibiotic therapy.
A breakthrough message for patients that must be delivered correctly by health care providers. The Undetectable Equals Untransmittable, or U=U, move­ment is a global campaign definitively stating that people living with HIV (PLWH) who have undetectable HIV RNA are unable to transmit HIV. By educating people, the hope is that they will get tested and, if necessary, start and stay on treatment. This message has been endorsed by many organizations, including the US Centers for Disease Control and Prevention and the HIV Medicine Association.
As current antibiotics become less effective due to bacterial resistance, there is high demand for new and effective therapies with both IV and oral formulations.